ATG10-AS1

Across TCGA pan-cancer cohorts, ATG10-AS1 RNA is linked to patient survival in 12 of 34 cancer types, making it the most broadly survival-associated ATG10-AS1 data layer.

The strongest signal is observed in bladder urothelial carcinoma (BLCA), where higher ATG10-AS1 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated ATG10-AS1 expression acts as an unfavorable survival marker, although some lineages such as LAML and LUAD show a favorable association.

BLCA, STAD, and ESCA are the cancer types where ATG10-AS1 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
BLCA	OS	Tertile	II,III,IV	0.539	0.730	.002	117	view →
STAD	DFS	Tertile	II,III,IV	0.504	0.666	.004	51	view →
ESCA	OS	Quartile	All	0.326	0.584	.001	37	view →
OV	OS	Tertile	IV	0.355	0.659	.007	30	view →
LAML	DFS	Quartile	All	0.605	0.221	<.001	28	view →
READ	DFS	Tertile	III,IV	0.082	0.746	<.001	27	view →
SKCM	OS	Tertile	II,III,IV	0.288	0.740	.002	21	view →
CHOL	DFS	Tertile	All	0.126	0.513	.032	18	view →
KIRP	OS	Tertile	II,III,IV	0.270	0.751	.032	18	view →
UCEC	OS	Tertile	IV	0.308	0.748	.009	18	view →
LUAD	DFS	Tertile	All	0.847	0.631	.021	15	view →
HNSC	OS	Tertile	II,III,IV	0.850	0.377	.041	9	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 12 lineages.

ATG10-AS1–BLCA (OS)

Open the BLCA breakdown →